Adenocarcinoma(an NSCLC) is the most common type of lung cancer, making up 30%-40% of all cases. Squamous cell carcinoma(an NSCLC) is the second most common type of lung cancer, making up about 30% of all cases. Large cell cancer (another NSCLC) makes up 10% of all cases. SCLC ma...
PURPOSE: The cancer/testis antigen XAGE1 (GAGED2a) is expressed in approximately 40% of advanced lung adenocarcinomas. We investigated the clinical relevance of the XAGE1 (GAGED2a) immune responses in patients with advanced lung adenocarcinoma. EXPERIMENTAL DESIGN: The XAGE1 (GAGED2a) antigen ...
Most lung cancers are NSCLC, including squamous cell carcinoma and adenocarcinoma of the lung. Small-cell lung cancer accounts for only approximately 15% of all cases of lung cancer. People should seek medical care when experiencing shortness of breath, unexplained weight loss, chest pain that ...
Active human papillomavirus involvement in Barrett’s dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway. Int J Cancer. 2017;141(10):2037-2049. doi:10.1002/ijc.30896PubMedGoogle ScholarCrossref 10. El-Serag HB, Hollier...
NSCLC Histology and Staging Adenocarcinoma was the most common histologic finding (54.7%) followed by squamous cell (29.4%) in the SEER-NPCR database (57.1% and 27.6%, respectively, in SEER-18) (eAppendix C, eTable 1 in the Supplement). The frequency distribution of NSCLC stages by histol...
All cases were adenocarcinoma, 60% of patients had a known or suspected driver mutations, mean age was 58, 67% were women, 70% were non-smokers, 27% initially presented with LM, 84% received systemic treatment at or after development of LM and 53% of these patients received modern ...
Morphology Squamous cell carcinomaAdenocarcinomaCombined Other 0.97 (0.90, 1.04)0.52 (0.46, 0.58)Reference <0.001 Stage I/IAIBII/IIAIIB 0.47 (0.42, 0.52)0.64 (0.58, 0.70)0.76 (0.68, 0.86)Reference <0.001 Synchronous Cancer Y vs N 1.42 (1.14, 1.76) 0.002 Multivariable Analysis – Including Tre...
There have been few investigations of cancer prognosis models based on Bayesian hierarchical models. In this study, we used a novel Bayesian method to screen mRNAs and estimate the effects of mRNAs on the prognosis of patients with lung adenocarcinoma. Based on the identified mRNAs, we can build...
mucinous adenocarcinoma) across different primary sites. A total of 80,967 cases of MACs during 1973 to 2014 diagnosed with first and only cancer diagnosis were identified. We excluded patients diagnosed by either autopsy or death certificate. In total, 80,758 patients were eventually eligible for...
Bevacizumab prevents brain metastases formation in lung adenocarcinoma. Mol Cancer Ther. 2016;15(4):702-710. doi:10.1158/1535-7163.MCT-15-0582 PubMedGoogle ScholarCrossref 16. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours...